4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-21-049120
Chief Legal Officer sold 12,500 shares at $45.00 ($562,500)
- Chief Legal Officer acquired 12,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Siegel Jolie Chief Legal Officer | 2021-07-29 | Option exercise | +12,500 | $4.98 | $62,250 | 12,500 | D |
| Siegel Jolie Chief Legal Officer | 2021-07-29 | Sale | −12,500 | $45.00 | $562,500 | 0 | D |
| Derivatives | |||||||
| Siegel Jolie Chief Legal Officer | 2021-07-29 | Option exercise · Stock Option (Right to Buy) | −12,500 | 283,821 | D | ||
| Open-market sales · 12,500 sh · avg $45.00 · $562,500 | |||||||
Loading xslF345X03/doc4.xml…